Royalty Pharma PLC - Common Stock (RPRX)

CUSIP: 76028H209

Q3 2017 13F Holders as of 30 Sep 2017

Holder snapshot 6 signals
Share change
-88,882
SEC-reported price per share
$0.32
Number of holders
21
Value change
-$42,123
Number of buys
7
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
429,232,034

Security key

76028H209

Report period

Q3 2017

Institutions

21

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma PLC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Jun 2017
13F Highest disclosed value: $709,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $709K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $709K
RENAISSANCE TECHNOLOGIES LLC $440K
VANGUARD GROUP INC $366K
BlackRock Finance, Inc. $315K
GENERAL AMERICAN INVESTORS CO INC $239K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$709,000
1,540,844 shares
— 30 Jun 2017
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$440,000
956,013 shares
— 30 Jun 2017
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$366,000
794,303 shares
— 30 Jun 2017
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$315,000
685,127 shares
— 30 Jun 2017
GENERAL AMERICAN INVESTORS CO INC
13F
Company
13F
—
denominator unverified
$239,000
519,829 shares
— 30 Jun 2017
Allegis Investment Advisors, LLC
13F
Company
13F
—
denominator unverified
$183,000
398,792 shares
— 30 Jun 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
21
Shares
5,363,655
Rows available
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
21
Q3 2017 holders
21
Holder diff
0
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 value Q3 2017 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .